Your browser doesn't support javascript.
loading
Molecular Features of Cancers Exhibiting Exceptional Responses to Treatment.
Wheeler, David A; Takebe, Naoko; Hinoue, Toshinori; Hoadley, Katherine A; Cardenas, Maria F; Hamilton, Alina M; Laird, Peter W; Wang, Linghua; Johnson, Adrienne; Dewal, Ninad; Miller, Vincent; Piñeyro, David; Castro de Moura, Manuel; Esteller, Manel; Shen, Hui; Zenklusen, Jean Claude; Tarnuzzer, Roy; McShane, Lisa M; Tricoli, James V; Williams, Paul M; Lubensky, Irina; O'Sullivan-Coyne, Geraldine; Kohn, Elise C; Little, Richard F; White, Jeffrey; Malik, Shakun; Harris, Lyndsay; Weil, Carol; Chen, Alice P; Karlovich, Chris; Rodgers, Brian; Shankar, Lalitha; Jacobs, Paula; Nolan, Tracy; Hu, Jianhong; Muzny, Donna M; Doddapaneni, Harshavardhan; Korchina, Viktoriya; Gastier-Foster, Julie; Bowen, Jay; Leraas, Kristen; Edmondson, Elijah F; Doroshow, James H; Conley, Barbara A; Ivy, S Percy; Staudt, Louis M.
Afiliação
  • Wheeler DA; Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX 77030, USA; Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA.
  • Takebe N; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD 20892, USA.
  • Hinoue T; Van Andel Institute, Grand Rapids, MI 49503, USA.
  • Hoadley KA; Department of Genetics, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
  • Cardenas MF; Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX 77030, USA; Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA.
  • Hamilton AM; Department of Genetics, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
  • Laird PW; Van Andel Institute, Grand Rapids, MI 49503, USA.
  • Wang L; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Johnson A; Foundation Medicine Inc, Cambridge, MA 02141, USA.
  • Dewal N; Foundation Medicine Inc, Cambridge, MA 02141, USA.
  • Miller V; Foundation Medicine Inc, Cambridge, MA 02141, USA.
  • Piñeyro D; Josep Carreras Leukaemia Research Institute, Badalona, 08916 Barcelona, Catalonia, Spain; Institucio Catalana de Recerca i Estudis Avançats (ICREA), 08010 Barcelona, Catalonia, Spain.
  • Castro de Moura M; Josep Carreras Leukaemia Research Institute, Badalona, 08916 Barcelona, Catalonia, Spain.
  • Esteller M; Josep Carreras Leukaemia Research Institute, Badalona, 08916 Barcelona, Catalonia, Spain; Centro de Investigacion Biomedica en Red Cancer (CIBERONC), 28029 Madrid, Spain; Institucio Catalana de Recerca i Estudis Avançats (ICREA), 08010 Barcelona, Catalonia, Spain; Physiological Sciences Department,
  • Shen H; Van Andel Institute, Grand Rapids, MI 49503, USA.
  • Zenklusen JC; Center for Cancer Genomics, National Cancer Institute, Bethesda, MD 20892, USA.
  • Tarnuzzer R; Center for Cancer Genomics, National Cancer Institute, Bethesda, MD 20892, USA.
  • McShane LM; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD 20892, USA.
  • Tricoli JV; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD 20892, USA.
  • Williams PM; Frederick National Laboratory for Cancer Research, Frederick, MD 21701, USA.
  • Lubensky I; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD 20892, USA.
  • O'Sullivan-Coyne G; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD 20892, USA.
  • Kohn EC; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD 20892, USA.
  • Little RF; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD 20892, USA.
  • White J; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD 20892, USA.
  • Malik S; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD 20892, USA.
  • Harris L; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD 20892, USA.
  • Weil C; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD 20892, USA.
  • Chen AP; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD 20892, USA.
  • Karlovich C; Frederick National Laboratory for Cancer Research, Frederick, MD 21701, USA.
  • Rodgers B; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD 20892, USA.
  • Shankar L; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD 20892, USA.
  • Jacobs P; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD 20892, USA.
  • Nolan T; Department of Biomedical Informatics, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.
  • Hu J; Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX 77030, USA.
  • Muzny DM; Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX 77030, USA.
  • Doddapaneni H; Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX 77030, USA.
  • Korchina V; Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX 77030, USA.
  • Gastier-Foster J; Nationwide Children's Hospital, Columbus, OH 43205, USA.
  • Bowen J; Nationwide Children's Hospital, Columbus, OH 43205, USA.
  • Leraas K; Nationwide Children's Hospital, Columbus, OH 43205, USA.
  • Edmondson EF; Pathology and Histology Laboratory, Frederick National Laboratory for Cancer Research, National Cancer Institute, NIH, Frederick, MD 21701, USA.
  • Doroshow JH; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD 20892, USA.
  • Conley BA; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD 20892, USA.
  • Ivy SP; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD 20892, USA.
  • Staudt LM; Center for Cancer Genomics, National Cancer Institute, Bethesda, MD 20892, USA. Electronic address: lstaudt@mail.nih.gov.
Cancer Cell ; 39(1): 38-53.e7, 2021 01 11.
Article em En | MEDLINE | ID: mdl-33217343
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Variação Genética / Genômica / Redes Reguladoras de Genes / Neoplasias / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Female / Humans / Male Idioma: En Revista: Cancer Cell Assunto da revista: NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Variação Genética / Genômica / Redes Reguladoras de Genes / Neoplasias / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Female / Humans / Male Idioma: En Revista: Cancer Cell Assunto da revista: NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos